Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer

研究成果: 雜誌貢獻文章同行評審

6 引文 斯高帕斯(Scopus)

指紋

深入研究「Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer」主題。共同形成了獨特的指紋。

Medicine & Life Sciences

Chemical Compounds